Research questionnaire – Women’s Ectopic Pregnancy Treatment Experiences

One of the key things that we believe at the Ectopic Pregnancy Trust is the importance of treatment choice.  When someone is, sadly, diagnosed with an Ectopic Pregnancy we believe that there should be as many options as possible available for treatment and that a woman should have a right to choose which method she thinks will be most suitable for her.

Methotrexate is one such form of treatment where the medicine is injected into the muscle and works to remove folate from the body to stop the ectopic pregnancy cells from dividing.  This method of treatment, as opposed to surgery where the tube is typically removed, preserves the fallopian tube and enables a faster physical recovery time.  The downside of methotrexate is it can have temporary side effects where the lady feels very ill.  Methotrexate sometimes requires a second injection and is successful in 66-95% of cases depending upon the study.

A new study has found that using the lung cancer drug gefitinib in addition to the current drug methotrexate is more effective at helping treat an ectopic pregnancy than the conventional drug alone and could therefore reduce the need to remove the fallopian tube in a significant number of cases and would also reduce the need for a second methotrexate injection.  The study, published in the journal Obstetrics and Gynaecology, involved a trial of 12 women with ectopic pregnancies.

A group of researchers, led by Dr Andrew Horne of the University of Edinburgh, now wants to run a large trial to prove their initial studies and make the use of gefitinib alongside methotrexate a standard treatment option for women in the future.  The team aims to make treating ectopic pregnancies more effective using drugs rather than surgery to reduce the physical and emotional recovery times for women in the future.  They are planning a clinical trial to test the new treatment and are keen to have input from women who have experienced an ectopic pregnancy to know whether this treatment option would be something that is wanted.

This very short survey will only take a minute or two to complete and we would be very grateful if you could share your point of view on whether it is a good idea.